Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Title: Conduct of anaesthesia during acute ischaemic stroke: a retrospective case series of patients undergoing mechanical thrombectomy.
Design: This study will be a retrospective consecutive observational case series
The Aim of this study is to describe the baseline characteristics, procedural and post-operative clinical characteristics of anaesthetic care delivered to consecutive adult patients who underwent mechanical thrombectomy as part of their routine clinical care between 01/01/2016 and 01/10/2020 at Nottingham University Hospitals NHS Trust (sample size approximately 250).
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Evaluating the number of patients requiring mechanical thrombectomy | This retrospective study will identify the anaesthetic care delivered to a group of patients undergoing mechanical thrombectomy for the management of acute ischaemic stroke. The data collected will be from all patients that received this treatment between 01/01/2016 and 01/10/2020 at Nottingham University Hospitals NHS Trust. This data written up and of interest both to our organisation and to comparable neuroscience centres in the UK and internationally. Outcomes that will be measured in this clinical case study are highlighted below. | Through study completion, up to 9 months |
| Measure | Description | Time Frame |
|---|---|---|
| Background information: Age (>/= 18 years of age) | Through study completion, up to 9 months | |
| Background information: Gender (male or female) | Physiological gender | Through study completion, up to 9 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Participants will be identified by existing clinical records of mechanical thrombectomy procedures undertaken at Nottingham University Hospitals and already collated as part of routine service evaluation and clinical care. Sampling will be consecutive. The sampling window (01/01/2016-01/10/2020) has been chosen because mechanical thrombectomy is a new therapy that was not undertaken in current form before 2016.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| David Hewson (Consultant Anaesthetist) | Contact | 01159249924 | 61195 | david.hewson@nuh.nhs.uk |
| Heather Broll (Junior Doctor) | Contact | 07717277759 | heather.broll@nhs.net |
| Name | Affiliation | Role |
|---|---|---|
| David Hewson (Consultant Anaesthetist) | Nottingham University Hospitals NHS Trust | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D000083242 | Ischemic Stroke |
| D007511 | Ischemia |
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Background information: The degree of disability/dependence after a stroke will be measured using the presenting modified Rankin Score | 0 - No symptoms.
| Through study completion, up to 9 months |
| Background information: Presenting blood pressure (systolic and diastolic) | Through study completion, up to 9 months |
| Background information: Presenting heart rate (beats per minute) | Through study completion, up to 9 months |
| Background information: The fitness of the patient will be measured using the American Society of Anaesthetists Classification | ASA I A normal healthy patient Healthy ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes | Through study completion, up to 9 months |
| Background information: Height of the patient (m) | BMI = Weight / (height x height) | Through study completion, up to 9 months |
| Background information: Weight of the patient (kg) | BMI = Weight / (height x height) | Through study completion, up to 9 months |
| Background information: Measuring the distance from referring hospital (miles) | Hospitals included: Kings Mill Hospital, Royal Derby Hospital, Leicester, Lincoln, Boston, Burton | Through study completion, up to 9 months |
| The patient's stroke classification will be measured using National Institute for Health Stroke Scale | 1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke | Through study completion, up to 9 months |
| Mode of anaesthesia | Awake / Sedated / Converted on-table to General Anaesthetic / GA. | Through study completion, up to 9 months |
| To identify the anaesthetic agents used | Propofol / Alfentanil / Remifentanil / Fentanyl / Midazolam | Through study completion, up to 9 months |
| The level of the anaesthetist (registrar / consultant) | Through study completion, up to 9 months |
| Intra - procedural observations: Measuring time spent with systolic blood pressure (mmHg) <10% of presenting BP (minutes) | Through study completion, up to 9 months |
| Intra - procedural observations: Quantifying any episodes of hypoxia (SpO2 <94%) | Through study completion, up to 9 months |
| Intra-procedural interventions: Identifying if the patient required vasopressors | None / metaraminol / ephedrine / noradrenaline | Through study completion, up to 9 months |
| Measuring the response of treatment using the post-procedural Thrombolysis in Cerebral Infarction scale | Grade 0: no perfusion Grade 1: penetration with minimal perfusion Grade 2: partial perfusion Grade 2A: only partial filling (less than two-thirds) of the entire vascular territory is visualised Grade 2B: complete filling of all of the expected vascular territory is visualised but the filling is slower than normal Grade 3: complete perfusion | Through study completion, up to 9 months |
| To identify the level of care required immediately post procedure (Level 0,1,2,3) | Through study completion, up to 9 months |
| Identify the duration of Intensive Care stays (days) | Through study completion, up to 9 months |
| Identify the duration of stay in hospital (days) | Whether in NUH or otherwise | Through study completion, up to 9 months |
| To measure the long term outcome: National Institute for Health Stroke Scale at 24 hours post-procedure | 1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke | Through study completion, up to 9 months |
| To measure the long term outcome: Modified Rankin Score at 90 days | 0 - No symptoms.
| Through study completion, up to 9 months |
| To measure the long term outcome: Mortality at 90 days (survived / deceased) | Through study completion, up to 9 months |
| To measure the long term outcome: Discharge destination (home / institution) | Through study completion, up to 9 months |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |